[1] Roufosse, F., & Weller, P. F. (2010). Practical approach to the patient with hypereosinophilia.The Journal of allergy and clinical immunology, 126(1), 39–44. https://doi.org/10.1016/j.jaci.2010.04.011

[2] Butt, N. M., Lambert, J., Ali, S., Beer, P. A., Cross, N. C., Duncombe, A., Ewing, J., Harrison, C. N., Knapper, S., McLornan, D., Mead, A. J., Radia, D., Bain, B. J., & British Committee for Standards in Haematology (2017). Guideline for the investigation and management of eosinophilia.British journal of haematology, 176(4), 553–572. https://doi.org/10.1111/bjh.14488

[3] Valent, P., Klion, A. D., Horny, H. P., Roufosse, F., Gotlib, J., Weller, P. F., Hellmann, A., Metzgeroth, G., Leiferman, K. M., Arock, M., Butterfield, J. H., Sperr, W. R., Sotlar, K., Vandenberghe, P., Haferlach, T., Simon, H. U., Reiter, A., & Gleich, G. J. (2012). Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.The Journal of allergy and clinical immunology, 130(3), 607–612.e9. https://doi.org/10.1016/j.jaci.2012.02.019

[4] Jallal, H., Belabbes, S., & Khatouri, A. (2022). An unusual tropical endomyocardial fibrosis: a case report.The Pan African medical journal, 41, 8. https://doi.org/10.11604/pamj.2022.41.8.32886

[5] Weller, P. F., & Bubley, G. J. (1994). The idiopathic hypereosinophilic syndrome.Blood, 83(10), 2759–2779.

[6] Piccirillo, F., Mastroberardino, S., Nafisio, V., Fiorentino, M., Segreti, A., Nusca, A., Ussia, G. P., & Grigioni, F. (2024). Eosinophilic Myocarditis: From Bench to Bedside.Biomedicines, 12(3), 656. https://doi.org/10.3390/biomedicines12030656

[7] Polito, M. V., Hagendorff, A., Citro, R., Prota, C., Silverio, A., De Angelis, E., Klingel, K., Metze, M., Stöbe, S., Hoffmann, K. T., Sabri, O., Piscione, F., & Galasso, G. (2020). Loeffler's Endocarditis: An Integrated Multimodality Approach. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 33(12), 1427–1441. https://doi.org/10.1016/j.echo.2020.09.002

[8] Fauci, A. S., Harley, J. B., Roberts, W. C., Ferrans, V. J., Gralnick, H. R., & Bjornson, B. H. (1982). NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.Annals of internal medicine, 97(1), 78–92. https://doi.org/10.7326/0003-4819-97-1-78

[9] Ogbogu, P. U., Bochner, B. S., Butterfield, J. H., Gleich, G. J., Huss-Marp, J., Kahn, J. E., Leiferman, K. M., Nutman, T. B., Pfab, F., Ring, J., Rothenberg, M. E., Roufosse, F., Sajous, M. H., Sheikh, J., Simon, D., Simon, H. U., Stein, M. L., Wardlaw, A., Weller, P. F., & Klion, A. D. (2009). Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. The Journal of allergy and clinical immunology, 124(6), 1319-25.e3. https://doi.org/10.1016/j.jaci.2009.09.022

[10] Roufosse, F. E., Goldman, M., & Cogan, E. (2007). Hypereosinophilic syndromes.Orphanet journal of rare diseases, 2, 37. https://doi.org/10.1186/1750-1172-2-37

[11] Chao, B. H., Cline-Parhamovich, K., Grizzard, J. D., & Smith, T. J. (2007). Fatal Loeffler's endocarditis due to hypereosinophilic syndrome.American journal of hematology, 82(10), 920–923. https://doi.org/10.1002/ajh.20933

[12] Brambatti, M., Matassini, M. V., Adler, E. D., Klingel, K., Camici, P. G., & Ammirati, E. (2017). Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes.Journal of the American College of Cardiology, 70(19), 2363–2375. https://doi.org/10.1016/j.jacc.2017.09.023

[13] Antonopoulos, A. S., Azzu, A., Androulakis, E., Tanking, C., Papagkikas, P., & Mohiaddin, R. H. (2021). Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonance.European heart journal. Cardiovascular Imaging, 22(11), 1273–1284. https://doi.org/10.1093/ehjci/jeaa346

[14] Hwang, J. W., Kim, H., Cho, S. W., Shin, Y. C., Kim, H. S., Cho, Y. J., & Kwak, J. J. (2020). Idiopathic hypereosinophilic syndrome with intracardiac atypical linear-shaped and floating thrombus presenting as embolic cerebral infarction.Journal of cardiology cases, 23(5), 193–197. https://doi.org/10.1016/j.jccase.2020.10.015

[15] Rohmer, J., Groh, M., Samson, M., London, J., Jachiet, M., Rouzaud, D., Paule, R., Suarez, F., Lefèvre, G., Cohen, F., Lambotte, O., Perlat, A., Bielefeld, P., Guillevin, L., Kahn, J. E., Terrier, B., & French Vasculitis Study Group (FVSG) (2019). Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: A case study and literature review.Autoimmunity reviews, 18(8), 828–830. https://doi.org/10.1016/j.autrev.2019.06.004

[16] Jin, X., Ma, C., Wang, Y., & Yang, J. (2017). A Case of Loeffler Endocarditis That Showed Endomyocardial Systolic Dysfunction Detected by Layer Specific Strain Analysis.International heart journal, 58(6), 1001–1003. https://doi.org/10.1536/ihj.16-422

[17] Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., & Friedrich, M. G. (2018). Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.Journal of the American College of Cardiology, 72(24), 3158–3176. https://doi.org/10.1016/j.jacc.2018.09.072

[18] Salemi, V. M., Rochitte, C. E., Shiozaki, A. A., Andrade, J. M., Parga, J. R., de Ávila, L. F., Benvenuti, L. A., Cestari, I. N., Picard, M. H., Kim, R. J., & Mady, C. (2011). Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients.  Cardiovascular imaging, 4(3), 304–311. https://doi.org/10.1161/CIRCIMAGING.110.950675

[19] Beck, K. S., Jeong, S. Y., Lee, K. Y., Chang, K., & Jung, J. I. (2016). Native T1 Mapping Demonstrating Apical Thrombi in Eosinophilic Myocarditis Associated with Churg-Strauss Syndrome.Korean circulation journal, 46(6), 882–885. https://doi.org/10.4070/kcj.2016.46.6.882

[20] Gastl, M., Behm, P., Jacoby, C., Kelm, M., & Bönner, F. (2017). Multiparametric cardiac magnetic resonance imaging (CMR) for the diagnosis of Loeffler's endocarditis: a case report.BMC cardiovascular disorders, 17(1), 74. https://doi.org/10.1186/s12872-017-0492-7

[21] Kuchynka, P., Palecek, T., Masek, M., Cerny, V., Lambert, L., Vitkova, I., & Linhart, A. (2016). Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis.BioMed research international, 2016, 2829583. https://doi.org/10.1155/2016/2829583

[22] Kumar, V., Harfi, T. T., He, X., McCarthy, B., Cardona, A., Simonetti, O. P., & Raman, S. V. (2019). Estimation of myocardial fibrosis in humans with dual energy CT.Journal of cardiovascular computed tomography, 13(6), 315–318. https://doi.org/10.1016/j.jcct.2018.12.004

[23] A New Gold Standard: Cardiac Mri And Fdg Pet In Diagnosis Of Eosinophilic MyocarditisRodrigues, Sonali Et Al.Chest, Volume 164, Issue 4, A4100

[24] Parikh, A, Trivieri, M, Lala, A. et al. PET/MRI: A NOVEL IMAGING MODALITY TO GUIDE TAILORED IMMUNOTHERAPY IN EOSINOPHILIC MYOCARDITIS. JACC. 2019 Mar, 73 (9_Supplement_1) 2891. https://doi.org/10.1016/S0735-1097(19)33497-7

[25] Taskesen, T., Osei, K., Hamilton, R., Marcus, R., Martin, E., & Manola, A. (2021). Eosinophilic Myocarditis: Is Endomyocardial Biopsy Essential for Diagnosis in the Era of Advanced Cardiac Imaging?. Journal of cardiovascular echography, 31(4), 251–254. https://doi.org/10.4103/jcecho.jcecho_125_20

[26] Mubarik A, Iqbal AM. Loeffler Endocarditis. [Updated 2024 Jan 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534850/